Patient demand and expectations are driving innovation amongst branded formulation developers. To increase convenience of dosages and medicines, multiple active pharmaceutical ingredients. need to be combined, thus increasing the complexity of processes. This complexity also comes from the need to develop and produced modified release products for different customer segments.
Pharmaceutical companies are also increasingly focused on developing products that can be patented, allowing them to exclusively produce and market certain own-brand products and maintain a competitive edge in an increasingly crowded space.
With the increasing shift in focus from small molecule to large molecule products (which require administration via injection), organizations are working to develop more safe and convenient methods by which to administer these medicines. While this includes efforts to develop oral formulations, there are several technical complications that can arise from this.
Cedar’s global team of expert consultants have helped their clients achieve significant success across the pharmaceutical industry and are strongly positioned to assist you in driving a breakthrough strategy for your organization.